China is once again expanding its export control list for drug precursor chemicals, this time adding two piperidone compounds — substances structurally related to a well-known fentanyl precursor — just ahead of a high-stakes summit between President Xi Jinping and US President Donald Trump. Exports of these chemicals to the US, Mexico, and Canada will now require government permits, according to China's commerce ministry.

This is at least the third such expansion in the past year, with previous additions made in May and November 2026 following bilateral summits. The moves come amid sustained US pressure on Beijing to crack down on the flow of fentanyl precursor chemicals, which fuel the deadly opioid epidemic in North America. China maintains that its counter-narcotics laws are among the world's strictest and frames fentanyl as primarily a US domestic problem.

Key Takeaways:

• China has added chemicals to its fentanyl precursor export control list at least three times in under a year, each tied to diplomatic milestones
• The two newly added chemicals are piperidone compounds, closely related to established fentanyl precursors
• Earlier tariffs Trump imposed over fentanyl concerns were halved after a prior Xi meeting, then struck down by the US Supreme Court in February

Why it matters: Fentanyl remains the leading driver of overdose deaths in the US. China's incremental export controls signal diplomatic progress, but policymakers continue to debate whether permit requirements alone are sufficient to meaningfully curb the supply chain fueling the opioid crisis.